Literature DB >> 23573315

Androgen-STAT3 activation may contribute to gender disparity in human simply renal cysts.

Min Liu1, Yun-Fei Xu, Yuan Feng, Wei Zhai, Jian-Ping Che, Sheng-Qiang Xia, Guang-Chun Wang, Jun-Hua Zheng.   

Abstract

BACKGROUND: Simple renal cysts (SRC) are a common urological disease mostly in elderly, however the male-to-female ratio was 2.81. Androgen receptor (AR) activation was initially proposed as a vital signaling pathway in prostate cancer and consequent signal transducer and activator of transcription 3 (STAT3)-AR complex led an important putative mechanism by which prostate cells are sensitized with growth factor signals. However, in SRC disease, no related study emerged.
METHODS: 30 patients with SRC and 20 age-matched healthy controls were recruited. Puncture biopsy was performed to acquire cyst-adjacent kidney tissue and normal kidney tissues were from healthy kidney donor who received living-related donor nephrectomy. The expression of STAT3 and androgen receptor was determined by immunohistochemical staining and western blotting. The in-vitro effect of androgen on human HK-2 (an immortalized proximal tubule epithelial cell line from normal adult human kidney) cells' STAT3 expression was analyzed as well.
RESULTS: Activated STAT3 was strongly expressed in tubular epithelial cells from kidneys of SRC patients, while it was barely found in normal kidneys. Meanwhile, the androgen receptor positive cyst epithelial cells and adjacent normal renal tubule cells were observed in kidneys from SRC patients, however, AR was weakly expressed in normal healthy male kidneys, statistically significant differences existed. In-vitro experiment demonstrated that when treated with exogenous added androgen, the expression level of STAT3 in HK-2 cells was significantly elevated.
CONCLUSIONS: Our data raised the possible novel evidence that androgen-STAT3 activation might contribute to gender disparity in human SRC disease and clarification the esoteric mechanisms will provide us attractive therapy target for cystic kidney disease.

Entities:  

Keywords:  Kidney; STAT3; androgen; epithelial cells; renal cysts

Mesh:

Substances:

Year:  2013        PMID: 23573315      PMCID: PMC3606858     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  Raging hormones: gender and renal disease.

Authors:  Sharon R Silbiger
Journal:  Kidney Int       Date:  2011-02       Impact factor: 10.612

2.  Sex and gender differences in cardiovascular-renal physiology and pathophysiology.

Authors:  Jane F Reckelhoff; Christine Maric
Journal:  Steroids       Date:  2010-06-02       Impact factor: 2.668

3.  Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.

Authors:  Wouter N Leonhard; Annemieke van der Wal; Zlata Novalic; Steven J Kunnen; Ron T Gansevoort; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Am J Physiol Renal Physiol       Date:  2011-02-23

4.  Testosterone-down-regulated Akt pathway during cardiac ischemia/reperfusion: a mechanism involving BAD, Bcl-2 and FOXO3a.

Authors:  Chunyan Huang; Hongmei Gu; Wenjun Zhang; Jeremy L Herrmann; Meijing Wang
Journal:  J Surg Res       Date:  2010-08-17       Impact factor: 2.192

5.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

6.  STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma.

Authors:  A Horiguchi; T Asano; K Kuroda; A Sato; J Asakuma; K Ito; M Hayakawa; M Sumitomo; T Asano
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

7.  Functional potentiation of leptin-signal transducer and activator of transcription 3 signaling by the androgen receptor.

Authors:  WuQiang Fan; Toshihiko Yanase; Yoshihiro Nishi; Seiichi Chiba; Taijiro Okabe; Masatoshi Nomura; Hironobu Yoshimatsu; Shigeaki Kato; Ryoichi Takayanagi; Hajime Nawata
Journal:  Endocrinology       Date:  2008-08-14       Impact factor: 4.736

Review 8.  Transcription factor Stat5a/b as a therapeutic target protein for prostate cancer.

Authors:  Zhiyong Liao; Jacqueline Lutz; Marja T Nevalainen
Journal:  Int J Biochem Cell Biol       Date:  2009-11-13       Impact factor: 5.085

9.  Somatic mosaicism of androgen receptor CAG repeats in colorectal carcinoma epithelial cells from men.

Authors:  Francesco Di Fabio; Carlos Alvarado; Adrian Gologan; Emad Youssef; Linda Voda; Elliot Mitmaker; Lenore K Beitel; Philip H Gordon; Mark Trifiro
Journal:  J Surg Res       Date:  2008-06-11       Impact factor: 2.192

10.  Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.

Authors:  Bin Liu; Zhong Ren; Yang Shi; Chao Guan; Zimin Pan; Zhihong Zong
Journal:  Laryngoscope       Date:  2008-11       Impact factor: 3.325

View more
  3 in total

1.  The prostate response to prolactin modulation in adult castrated rats subjected to testosterone replacement.

Authors:  Flávia B Constantino; Ana C L Camargo; Sérgio A A Santos; Ketlin T Colombelli; Laura F Martin; Marcia G Silva; Sérgio L Felisbino; Luis A Justulin
Journal:  J Mol Histol       Date:  2017-10-07       Impact factor: 2.611

2.  Prevalence, risk factors and clinical characteristics of renal dysfunction in Chinese outpatients with growth simple renal cysts.

Authors:  Qiaoru Wu; Chunhua Ju; Miaowen Deng; Xiaolong Liu; Zhongda Jin
Journal:  Int Urol Nephrol       Date:  2021-11-22       Impact factor: 2.266

3.  Icaritin inhibits JAK/STAT3 signaling and growth of renal cell carcinoma.

Authors:  Shasha Li; Saul J Priceman; Hong Xin; Wang Zhang; Jiehui Deng; Yong Liu; Jiabin Huang; Wenshan Zhu; Mingjie Chen; Wei Hu; Xiaomin Deng; Jian Zhang; Hua Yu; Guangyuan He
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.